The rapid development of single-cell transcriptomics, epigenomics, proteomics and metabolomics has resulted in a wave of new biological discoveries. Here we explore what this has meant for the cardiovascular field and what the future might hold for developing treatments for patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Libby, P. et al. Nat. Rev. Dis. Primers 5, 56 (2019).
Stary, H. C. et al. Circulation 92, 1355–1374 (1995).
Litviňuková, M. et al. Nature 588, 466–472 (2020).
Hu, Z. et al. Arterioscler. Thromb. Vasc. Biol. 41, 1408–1427 (2021).
Chaffin, M. et al. Nature 608, 174–180 (2022).
Kuppe, C. et al. Nature https://doi.org/10.1038/s41586-022-05060-x (2022).
Fernandez, D. M. et al. Nat. Med. 25, 1576–1588 (2019).
Wirka, R. C. et al. Nat. Med. 25, 1280–1289 (2019).
Pan, H. et al. Circulation 142, 2060–2075 (2020).
Zhao, T. X. et al. N. Engl. J. Med. Evid. https://doi.org/10.1056/EVIDoa2100009 (2021).
Zhao, T. X., Newland, S. A. & Mallat, Z. Arterioscler. Thromb. Vasc. Biol. 40, 853–864 (2020).
Rivellese, F. et al. Nat. Med. 28, 1256–1268 (2022).
Valdes-Mora, F. et al. Front. Immunol. 9, 2582 (2018).
Srivatsan, S. R. et al. Science 367, 45–51 (2020).
Hetzel, L. et al. Preprint at http://arxiv.org/abs/2204.13545 (2022).
Acknowledgements
T.X.Z. and Z.M. are supported by the British Heart Foundation, the NIHR Cambridge Biomedical Research Centre, Heart Research UK, and the UK Medical Research Council.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Zhao, T.X., Mallat, Z. Will gazing into the single-cell multiome illuminate cardiovascular drug development?. Nat Cardiovasc Res 2, 97–99 (2023). https://doi.org/10.1038/s44161-022-00209-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-022-00209-3